Acyclovir
What is it: A well-studied nucleoside analogue that interrupts herpes virus replication.AKA: Aciclovir, Sitavig, Zovirax- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
3 Resources
Referenced in this guide
3 Expert views
Contributed in this guide
31 Patient views
Contributed in this guide
Figure out what Acyclovir means for you
Page contents
Basics: What you need to know
Acyclovir is a nucleoside analogue antiviral medication designed to combat herpes simplex virus (HSV) and varicella‐zoster virus (VZV) by disrupting their ability to replicate. Although its primary focus is on herpes viruses, it occasionally garners questions about off‐label usage for various conditions. When considering it in the context of potential post‐viral syndromes such as Long Covid, formal research remains limited, and no official recommendations exist for its use in that scenario.
History and development
- First discovered: This antiviral was identified by researcher Howard Schaeffer in 1974, recognizing its specific action against herpes viruses.
- Commercial introduction: Originally developed by Burroughs Wellcome & Co., it gained prominence for treating HSV infections and later VZV.
- FDA approval: The medication was approved in the early 1980s for herpes‐related conditions, marking a new era of targeted antiviral therapy.
- Global adoption: Following successful trials, healthcare communities widely adopted it as a first‐line therapy against herpes viruses.
- Innovative formulations: Ongoing improvements led to the creation of topical creams, oral tablets, and a slow‐release patch for labial herpes, diversifying how the medication is used.
What is known
- Mechanism of action: It mimics the structure of naturally occurring nucleosides, getting incorporated into viral DNA and halting replication.
- Established uses: Effectively treats herpes simplex lesions (oral and genital) and varicella‐zoster infections like shingles, reducing outbreak duration and severity.
- Various forms: Oral forms, topical creams, and the adhesive patch (Sitavig) offer flexibility in administration and targeted application.
- Secondary benefits: May reduce overall viral shedding, lessening the risk of transmission; research also shows it can decrease the frequency of repeated outbreaks in immunocompromised individuals.
- Minimal cross‐activity: While it targets herpes viruses, it generally does not offer known direct activity against SARS‐CoV‐2, meaning its established value lies in HSV/VZV suppression rather than Long Covid relief.
What is not known
- Unclear role in Long Covid: There's no conclusive scientific evidence for this medication’s benefit in post‐acute COVID‐19 sequelae.
- Limited Long Covid studies: No large‐scale, peer‐reviewed trials confirm any effects on persistent viral or inflammatory processes related to SARS‐CoV‐2.
- Uncertain synergy: Its specific mechanism against herpes viruses doesn’t necessarily translate to direct effects on the coronavirus family.
- Long‐term impact: Although well‐studied for HSV/VZV, data remain scarce on long‐term usage for off‐label indications.
- Potential risk: Off‐label prescribing can carry unknown risks, including possible drug interactions, allergic reactions, or misuse.
- Mimics nucleosides: It integrates into viral DNA, halting replication pathways.
- Inhibits polymerase: By blocking the enzyme responsible for viral DNA synthesis.
- Targets active infection: Most effective on actively replicating herpes viruses.
- Requires viral enzyme: A viral kinase activates the drug, enhancing its selectivity.
- Gastrointestinal upset: Nausea or diarrhea can occur, especially with oral forms.
- Headache or dizziness: Mild neurological symptoms may arise in some patients.
- Local irritation: Topical forms can cause burning or stinging at application sites.
- Rare kidney concerns: High doses or dehydration may lead to kidney strain.
- Allergic reactions: Include rash, swelling, or itching; immediate assistance is recommended.
- Off‐label debates: Some speculate potential roles in non‐herpes conditions, but evidence is scarce.
- Limited clinical data: Supporters reference anecdotal symptom relief, yet no robust studies exist.
- Established scope: Critics emphasize its proven efficacy is confined to HSV/VZV.
- Safety versus efficacy: Many agree it’s relatively safe, but efficacy for other viruses remains unproven.
Patient views
Experiences
- Patients appreciate acyclovir for reducing symptoms like sound sensitivity and headaches.
- Some report faster recovery and improved stamina with acyclovir.
- Acyclovir is seen as a gentler option compared to other antivirals.
- It helps manage viral reactivations like EBV and shingles.
Challenges
- Side effects include sluggishness, peeling skin, and severe headaches.
- Some find acyclovir less effective compared to alternatives like valacyclovir.
- Kidney monitoring is necessary due to potential strain.
- Results can take months, leading to frustration.
Tips
- Start with a low dose and increase gradually.
- Take acyclovir with food for better absorption.
- Monitor kidney function during treatment.
- Be patient; improvements may take months.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
My doctor prescribed me acyclovir to try, similar medication, it hasn’t helped yet but it’s a little soon to say for sure
October 2024 • /r/covidlonghaulers
Patient view
I didn't do very well on Acyclovir but did on Valtrex (Valaciclovir). The Acyclovir made me feel sluggish, slow and poisoned and had no effect on my ME viral symptoms. The Valtrex had a good effect from the first week. Not sure why that is. Other individuals I know with ME who have been seen at the Breakspear report either side effects to the Acyclovir or no good effects. I'd start off slowly if I was in your position and then ask to switch to Valtrex if you find the side effects too much or have no good effects. Good luck.
November +46355 • Phoenix Rising Forum
Expert views
What they liked
- Experts appreciate acyclovir's accessibility and affordability.
- It has shown effectiveness against herpes family viruses.
- Some patients report significant symptom improvement.
- Experts value its role in managing viral reactivation.
What they didn't like
- Oral acyclovir has poor absorption compared to alternatives.
- Kidney issues are a rare but possible side effect.
- Limited effectiveness against non-herpes viruses.
- Long-term use may be required for sustained benefits.
What are they unsure about
- Experts are uncertain about acyclovir's role in non-herpes virus cases.
- Long-term effectiveness for chronic conditions remains unclear.
- Optimal duration of treatment is debated among experts.
- Experts question its efficacy in severe viral reactivation cases.
3 expert views
Expert view
Dr. Jennifer Curtin discusses the use of antivirals, including Acyclovir, in treating conditions like ME/CFS and Long COVID. She explains that Acyclovir is not well absorbed orally, leading to the development of Valacyclovir, which is more commonly used. Studies from institutions like Stanford have shown that antivirals can lead to significant improvement in about half of ME/CFS patients. Dr. Curtin prefers Famciclovir over Valacyclovir due to lower risks of kidney issues, although these risks are rare and manageable with proper hydration. She also mentions that certain viruses, like CMV and HHV6, require different antivirals, as Acyclovir and its derivatives are ineffective against them.
October 2024 • Fireside Chat Series. Episode 15 | Lessons from the US: Treating ME and Long COVID with Dr. Jennifer Curtin
Expert view
Dr. Jennifer Curtin discusses the use of antivirals, including Valacyclovir (Valtrex), for treating Long COVID and ME/CFS. She explains that Valacyclovir is a commonly used antiviral due to its effectiveness in studies conducted by Stanford and other institutions. While Valacyclovir is generally safe, Dr. Curtin prefers Famciclovir for its better absorption and lower risk of kidney issues. She also mentions that certain viruses like CMV and HHV-6 require different antivirals, as Valacyclovir is not effective against them. Dr. Curtin highlights the importance of hydration to minimize potential kidney risks when using Valacyclovir.
October 2024 • Fireside Chat Series. Episode 15 | Lessons from the US: Treating ME and Long COVID with Dr. Jennifer Curtin
What and who it targets
Patients with viral reactivation
Targets reactivation of latent viruses.
Immune-compromised individuals
Supports immune system against viral load.
Neurological symptom sufferers
May alleviate virus-related neurological issues.
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Requires a prescription from a healthcare provider.
- Typically prescribed off-label for Long Covid.
- Dosage varies; common regimens include 400 mg three to four times daily.
- Available at pharmacies with a prescription.
Cost
- Oral capsules (200 mg): $10–$15 for 5 capsules.
- Oral tablets (400 mg): $12–$20 for 5 tablets.
- Intravenous solution (50 mg/mL): $45–$50 for 100 mL.
- Prices vary by pharmacy and region; discounts may apply with coupons.
Insurance cover
- Commonly covered by health insurance for FDA-approved uses.
- Coverage for off-label use, such as Long Covid, may vary by provider and region.
- In the U.S., Medicare and private insurance plans often cover Acyclovir.
Locations
- Mayo Clinic: Known for comprehensive care and research on Long Covid.
- Cleveland Clinic: Offers specialized post-Covid care.
- Riverside University Health System: Provides Long Covid treatment options.
- Other clinics may offer Acyclovir off-label; consult local healthcare providers.
Frequently asked questions
Key resources
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
